If You Invested in Exela Techs Inc 6% SER B (XELAP)

Exela Techs Inc 6% Series B Preferred Stock (XELAP) represents a class of preferred equity issued by Exela Technologies, Inc., a business process automation and outsourcing company. While XELAP is a security of Exela, understanding the value and risk profile of this preferred stock requires an understanding of Exela’s broader business in data processing, hosting, and related services.

According to multiple company disclosures, Exela Technologies describes itself as a business process automation (BPA) and business process outsourcing (BPO) leader. The company states that it leverages a global footprint and proprietary technology to provide digital transformation solutions that aim to enhance quality, productivity, and end‑user experience. Exela reports that it serves more than 4,000 customers across approximately 50 countries and notes that this customer base includes over 60% of the Fortune 100.

Exela’s operations are built on foundational technologies spanning information management, workflow automation, and integrated communications. Based on the company’s own descriptions, its software and services include multi‑industry, departmental solution suites that address areas such as finance and accounting, human capital management, and legal management. Exela also highlights industry‑specific solutions for sectors including banking, healthcare, insurance, manufacturing, and the public sector.

The company emphasizes that it operates through cloud‑enabled platforms built on a configurable stack of automation modules. Across its disclosures, Exela notes that it has thousands of employees operating in roughly 20–21 countries, and that it positions itself as an end‑to‑end digital journey partner for global organizations dealing with large volumes of data and complex transaction processing.

Business Focus and Operating Segments

Exela’s public communications reference several key business areas and segments:

• Information and Transaction Processing Solutions (ITPS), which the company associates with substantial revenue and large‑scale processing capabilities.
• Healthcare Solutions, including the PCH Global platform, which Exela describes as an industry‑leading healthcare platform serving providers and payers and expanding its capabilities and customer base.
• Legal & Loss Prevention Services, which the company identifies as a distinct revenue‑generating area.
• Finance and Accounting Outsourcing (FAO), highlighted through a strategic partnership with recruitment firm Michael Page to expand Exela’s Center of Excellence and deploy models such as Build‑Operate‑Transfer, captive centers, and Business Processes as a Service for enterprise customers.

Exela also references specialized brands and business units within its structure. For example, Reaktr.ai is described as a global business unit focusing on AI‑powered cybersecurity and multi‑cloud services, while Rust Consulting is associated with breach remediation services. These elements underscore the company’s focus on automation, cybersecurity, and data‑intensive transaction environments.

Industry Position and Sector Exposure

Within the Information sector and the data processing, hosting, and related services industry, Exela positions itself as a provider of technology‑enabled solutions that address the life cycle of transaction processing and enterprise information management. Company materials explain that its solutions span activities such as enabling payment gateways and data exchanges across multiple systems, matching inputs against contracts and handling exceptions, depositing payments, and distributing communications.

Exela’s customer references cover multiple industries, including banking, healthcare, insurance, manufacturing, and the public sector, as well as broader enterprise functions like finance and accounting and human capital management. This breadth indicates that the performance of XELAP is indirectly tied to Exela’s ability to maintain and grow relationships across these verticals and functional areas.

Trading Venue and Listing Status

Exela has disclosed important information regarding the trading status of its securities, including XELAP. The company reported that on November 6, 2024, Nasdaq determined to delist Exela’s securities for failure to meet certain market value requirements, and that trading on Nasdaq was suspended on November 8, 2024. Following this suspension, Exela stated that its common stock and Series B preferred stock began trading on the OTC Markets system under the symbols "XELA" and "XELAP," respectively, effective November 8, 2024.

On January 7, 2025, Exela further announced that its Board of Directors had approved the commencement of a process to voluntarily delist its securities from Nasdaq and to deregister its securities under the U.S. Securities Exchange Act of 1934, citing factors such as the Nasdaq suspension and expected reductions in operating expenses associated with continued listing and reporting. The company indicated its intention to file a Form 25 to delist and, after meeting applicable criteria, a Form 15 to deregister, which would suspend and ultimately terminate its periodic reporting obligations. Exela also stated that it reserved the right to delay or withdraw these filings.

These developments are relevant for holders and prospective investors in XELAP, as they affect where and how the preferred shares trade and the level of ongoing public reporting by the issuer.

Strategic Initiatives and Partnerships

Exela has publicly described several strategic initiatives that illustrate how it applies its data processing and automation capabilities:

• A strategic partnership with Michael Page, under which Michael Page plans to expand Exela’s Center of Excellence across corporate functions, including Finance Shared Services, and deploy Build‑Operate‑Transfer, captive, and Business Processes as a Service models to enterprise customers.
• A strategic alliance with AIDEO Technologies aimed at integrating AI‑driven autonomous medical coding into Exela’s healthcare offerings, particularly through the PCH Global platform, to enhance efficiency and accuracy in medical billing.
• A breach remediation contract valued at over $35 million, which Exela associates with its ITPS segment and describes as an example of its ability to quickly scale capacity and deliver customer remediation solutions through brands such as Reaktr.ai, Rust Consulting, and Exela Technologies BPA LLC.
• The launch of SecAi, an AI‑powered cybersecurity service from the Reaktr business unit, on Oracle Cloud Infrastructure, positioned as a configurable generative AI validation framework supporting numerous large language models and integrations with external data sources and security frameworks.

Exela has also announced that its Board authorized the company to consider a spin‑off of Exela Technologies BPA, LLC, its business process automation business, to Exela stockholders. The company indicated that, if completed, this potential spin‑off would separate the BPA business into a new holding company while existing Exela stockholders would continue to own Exela, including its majority interest in XBP Europe Holdings, Inc. Exela has cautioned that there can be no assurance that such a transaction will be completed as described or at all.

Implications for XELAP Investors

Because XELAP is a Series B preferred stock of Exela Technologies, its risk and return characteristics are closely linked to Exela’s financial condition, capital structure, and strategic direction. Company disclosures, including quarterly results, highlight factors such as operating performance, segment revenues, operating losses, and debt levels. Exela has also sought stockholder approval for amendments to the certificate of designations of the Series B Cumulative Convertible Perpetual Preferred Stock, including provisions related to how dividends may be paid and the timing and amount of such payments, which are directly relevant to holders of XELAP.

Investors researching XELAP may therefore wish to review Exela’s historical financial statements, segment information, and any documents relating specifically to the terms of the Series B preferred stock, as well as company announcements regarding listing status, deregistration plans, and potential corporate transactions such as the contemplated BPA spin‑off.